We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+5.04%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.02%
AUM
$9.85B
AUM Growth
+$544M
Cap. Flow
+$305M
Cap. Flow %
3.1%
Top 10 Hldgs %
10.6%
Holding
1,507
New
131
Increased
296
Reduced
233
Closed
100

Top Buys

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$69.7M
2
WBA
Walgreens Boots Alliance
WBA
+$62.8M
3
EXR icon
Extra Space Storage
EXR
+$62.1M
4
APC
Anadarko Petroleum
APC
+$58.4M
5
CI icon
Cigna
CI
+$58.3M

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$70.2M
2
SRE icon
Sempra
SRE
+$62.5M
3
LNC icon
Lincoln National
LNC
+$62.2M
4
XL
XL Group Ltd.
XL
+$60.6M
5
NEE icon
NextEra Energy
NEE
+$58.5M

Sector Composition

Rank Sector Weight
1 Financials 23.55%
2 Industrials 12.89%
3 Consumer Discretionary 12.47%
4 Healthcare 10.29%
5 Technology 10.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ISSC icon
1126
Innovative Solutions & Support
ISSC
$327M
$504K 0.01%
173,354
– –
CSPI icon
1127
CSP Inc
CSPI
$79.7M
$503K 0.01%
102,200
– –
TWI icon
1128
Titan International
TWI
$466M
$501K 0.01%
46,700
-50,000
-52% -$579K
NTIC icon
1129
Northern Technologies International Corp
NTIC
$76.2M
$499K 0.01%
27,900
– –
EGRX
1130
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$499K 0.01%
6,600
– –
IWD icon
1131
iShares Russell 1000 Value ETF
IWD
$82.2B
$498K 0.01%
+4,100
New +$499K
ACCS
1132
ACCESS Newswire
ACCS
$25.6M
$497K 0.01%
25,000
– –
UTI icon
1133
Universal Technical Institute
UTI
$2.16B
$495K 0.01%
157,000
– –
SYNC
1134
DELISTED
Synacor, Inc.
SYNC
$493K 0.01%
246,500
+23,500
+11% +$42.8K
CRR
1135
DELISTED
Carbo Ceramics Inc.
CRR
$492K 0.01%
53,600
– –
CDTX
1136
DELISTED
Cidara Therapeutics
CDTX
$489K 0.01%
4,700
– –
LUMO
1137
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$489K 0.01%
11,411
– –
CRD.B icon
1138
Crawford & Co Class B
CRD.B
$491M
$488K 0.01%
56,400
– –
CORT icon
1139
Corcept Therapeutics
CORT
$12.4B
$487K ﹤0.01%
31,000
– –
AP icon
1140
Ampco-Pittsburgh
AP
$163M
$486K ﹤0.01%
47,383
-3,116
-6% -$31.3K
VERO
1141
DELISTED
Venus Concept
VERO
$486K ﹤0.01%
+57
New +$558K
SRT
1142
DELISTED
Startek Inc.
SRT
$486K ﹤0.01%
77,200
-26,500
-26% -$204K
PZN
1143
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$486K ﹤0.01%
52,800
– –
SRRA
1144
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$486K ﹤0.01%
4,108
-1,250
-23% -$125K
SBGI icon
1145
Sinclair Inc
SBGI
$992M
$485K ﹤0.01%
15,100
– –
TEN
1146
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$484K ﹤0.01%
+11,000
New +$530K
MFNC
1147
DELISTED
Mackinac Financial Corporation
MFNC
$484K ﹤0.01%
29,200
– –
ESTE
1148
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
$483K ﹤0.01%
54,602
– –
JAKK icon
1149
Jakks Pacific
JAKK
$301M
$482K ﹤0.01%
14,710
– –
ALIM
1150
DELISTED
Alimera Sciences
ALIM
$479K ﹤0.01%
32,655
-6,667
-17% -$93.7K
44 45
46
47 48

Similar funds

CFC
Cincinnati Financial Corp Fairfield, Ohio $4.96B AUM 18.21% 1-Year Est. Return
SNT
SIG North Trading Bala Cynwyd, Pennsylvania $4.98B AUM 36.24% 1-Year Est. Return
MA
Marshfield Associates Washington, District of Columbia $4.99B AUM 1.59% 1-Year Est. Return
FFB
First Financial Bankshares Abilene, Texas $4.95B AUM 25.06% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
SGM
Skye Global Management West Palm Beach, Florida $5B AUM 11.9% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
SMFG
Sumitomo Mitsui Financial Group Tokyo, Japan $4.94B AUM 1.39% 1-Year Est. Return

Bridgeway Capital Management's Q2 2018 Portfolio in Review

As of Q2 2018, Bridgeway Capital Management held 1,507 positions worth $9.85B, up 5.8% from $9.31B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Bridgeway Capital Management deployed $305M of net new capital in Q2 2018, opening 131 new positions and adding to 296 existing holdings. Its largest new stake was Morgan Stanley: 1,333,400 shares worth $63.2M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 23% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Lam Research, an estimated $70.2M trimmed.

  • Bridgeway Capital Management's largest Q2 2018 buy was Morgan Stanley: 1,333,400 shares worth $63.2M.
  • Bridgeway Capital Management added most to Cigna in Q2 2018, an estimated $58.3M increase.
  • Bridgeway Capital Management's biggest Q2 2018 reduction was Lam Research, cutting an estimated $70.2M.
  • Bridgeway Capital Management fully exited Sempra in Q2 2018, selling an estimated $62.5M.
  • Bridgeway Capital Management's ten largest holdings make up 11% of its $9.85B portfolio in Q2 2018.
  • Bridgeway Capital Management opened 131 new positions and closed 100 in Q2 2018.
  • Bridgeway Capital Management's portfolio value rose 5.8% quarter-over-quarter to $9.85B.

Based on Bridgeway Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.